[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f_KDMwuQ5-u_GPMaDuXA_YS1cJNhYJD2Mdn4RdVQ3mnk":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":8,"totalEnrollment":9,"activePrograms":10,"nonDrugCount":11,"topConditions":12,"upcomingReadouts":34,"phaseBuckets":35,"rows":42},"MedtronicNeuro",[4],74,false,3,19581,0,69,[13,16,19,22,25,27,30,32],{"name":14,"count":15},"Chronic Pain",8,{"name":17,"count":18},"Overactive Bladder",7,{"name":20,"count":21},"Epilepsy",6,{"name":23,"count":24},"Failed Back Surgery Syndrome",5,{"name":26,"count":24},"Parkinson's Disease",{"name":28,"count":29},"Fecal Incontinence",4,{"name":31,"count":29},"Parkinson Disease",{"name":33,"count":29},"Urinary Urge Incontinence",[],[36,37,38,39,40,41],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[43,70,97,124,149],{"intervention":44,"totalTrials":45,"cells":46},"intrathecal baclofen",1,{"EARLY_PHASE1":47,"PHASE1":49,"PHASE2":51,"PHASE3":53,"PHASE4":55,"NA":68},{"trials":48,"activeCount":10},[],{"trials":50,"activeCount":10},[],{"trials":52,"activeCount":10},[],{"trials":54,"activeCount":10},[],{"trials":56,"activeCount":10},[57],{"nctId":58,"briefTitle":59,"status":60,"phases":61,"primaryCompletion":62,"completion":62,"start":63,"enrollment":64,"conditions":65,"interventions":67},"NCT01032239","SISTERS: Spasticity In Stroke Study - Randomized Study","COMPLETED",[40],"2016-09","2009-11",61,[66],"Severe Spasticity",[44],{"trials":69,"activeCount":10},[],{"intervention":71,"totalTrials":45,"cells":72},"Optimal Medical Management",{"EARLY_PHASE1":73,"PHASE1":75,"PHASE2":77,"PHASE3":79,"PHASE4":81,"NA":95},{"trials":74,"activeCount":10},[],{"trials":76,"activeCount":10},[],{"trials":78,"activeCount":10},[],{"trials":80,"activeCount":10},[],{"trials":82,"activeCount":10},[83],{"nctId":84,"briefTitle":85,"status":60,"phases":86,"primaryCompletion":87,"completion":88,"start":89,"enrollment":90,"conditions":91,"interventions":94},"NCT01697358","Spinal Cord Stimulation for Predominant Low Back Pain",[40],"2016-03-12","2017-06-20","2013-01-08",278,[23,92,93],"Back Pain","Pain in Leg, Unspecified",[71],{"trials":96,"activeCount":10},[],{"intervention":98,"totalTrials":45,"cells":99},"Preservative-free morphine sulfate",{"EARLY_PHASE1":100,"PHASE1":102,"PHASE2":104,"PHASE3":106,"PHASE4":108,"NA":122},{"trials":101,"activeCount":10},[],{"trials":103,"activeCount":10},[],{"trials":105,"activeCount":10},[],{"trials":107,"activeCount":10},[],{"trials":109,"activeCount":10},[110],{"nctId":111,"briefTitle":112,"status":60,"phases":113,"primaryCompletion":114,"completion":114,"start":115,"enrollment":116,"conditions":117,"interventions":121},"NCT03761277","Embrace TDD: Post-Market Study to Evaluate Intrathecal Morphine as an Alternative to Systemic Opioids for Chronic Pain",[40],"2021-12-06","2019-01-16",93,[118,14,119,120],"Chronic Non-malignant Pain","Pain, Back","Pain, Leg",[98],{"trials":123,"activeCount":10},[],{"intervention":125,"totalTrials":45,"cells":126},"Standard Medical Therapy",{"EARLY_PHASE1":127,"PHASE1":129,"PHASE2":131,"PHASE3":133,"PHASE4":135,"NA":147},{"trials":128,"activeCount":10},[],{"trials":130,"activeCount":10},[],{"trials":132,"activeCount":10},[],{"trials":134,"activeCount":10},[],{"trials":136,"activeCount":10},[137],{"nctId":138,"briefTitle":139,"status":60,"phases":140,"primaryCompletion":141,"completion":141,"start":142,"enrollment":143,"conditions":144,"interventions":146},"NCT00547378","InSite for Over Active Bladder",[40],"2016-08","2007-10",571,[145,17],"Urinary Incontinence, Urgency-frequency",[125],{"trials":148,"activeCount":10},[],{"intervention":150,"totalTrials":45,"cells":151},"Intraspinal Gabapentin",{"EARLY_PHASE1":152,"PHASE1":154,"PHASE2":156,"PHASE3":170,"PHASE4":172,"NA":174},{"trials":153,"activeCount":10},[],{"trials":155,"activeCount":10},[],{"trials":157,"activeCount":10},[158],{"nctId":159,"briefTitle":160,"status":161,"phases":162,"primaryCompletion":163,"completion":164,"start":165,"enrollment":166,"conditions":167,"interventions":169},"NCT00414466","A Safety and Effectiveness Study of Intraspinal Gabapentin (MDT2004) for the Treatment of Chronic Pain","TERMINATED",[38],"2009-12","2010-08","2006-12",254,[168],"Chronic Intractable Pain",[150],{"trials":171,"activeCount":10},[],{"trials":173,"activeCount":10},[],{"trials":175,"activeCount":10},[]]